Skip to content

Turnstone Biologics Corp.

CIK 0001764974

← back to feed
Revenue (TTM)
$19.31M
−73.7% YoY Q2 Aug 2025
Net Income (TTM)
−$55.63M
−28.3% YoY Q2 Aug 2025
EPS Diluted (TTM)
−$2.41
+35.8% YoY Q2 Aug 2025
Gross Margin
—
Q2 Aug 2025
Operating Margin
-285.7%
Q2 Aug 2025
Net Margin
-288.2%
Q2 Aug 2025
Free Cash Flow (TTM)
−$67.67M
Q2 Aug 2025
Cash
$16.69M
Q2 Aug 2025
Total Debt
—
Q2 Aug 2025
Shares Outstanding
23.14M sh
Q2 Aug 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings